Sialyl Lewis<sup>X/A</sup> and Cytokeratin Crosstalk in Triple Negative Breast Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Carlota,Pascoal

第一单位： UCIBIO, Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal.

作者： Carlota,Pascoal ^[1] ; Mylène A,Carrascal ^[2] ; Daniela F,Barreira ^[3] ; Rita A,Lourenço ^[1] ; Pedro,Granjo ^[1] ; Ana R,Grosso ^[2] ; Paula,Borralho ^[1] ; Sofia,Braga ^[2] ; Paula A,Videira ^[1]

作者单位： UCIBIO, Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal. ^[1] Associate Laboratory i4HB-Institute for Health and Bioeconomy, NOVA School of Science and Technology, Universidade NOVA de Lisboa, 2819-516 Caparica, Portugal. ^[2] CDG & Allies-Professionals and Patient Associations International Network (CDG & Allies-PPAIN), 2819-516 Caparica, Portugal. ^[3] Instituto de Anatomia Patológica, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisboa, Portugal. ^[4] Unidade de Mama, Instituto CUF de Oncologia, 1998-018 Lisboa, Portugal. ^[5] NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1150-082 Lisbon, Portugal. ^[6]

关键词 aberrant glycosylation cytokeratin expression disease-free survival rate intermediate filament proteins sialyl LewisX/A (sLeX/A)triple-negative breast cancer (TNBC)α6 integrin

DOI 10.3390/cancers15030731

PMID 36765690

发布时间 2023-02-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交